What is IMPACT?

• The Association of Coloproctologists of Great Britain and Ireland (ACPGBI) launched the ‘Improving outcomes in Advanced Colorectal Tumours – IMPACT’ initiative in May 2017
  

Why IMPACT?

• IMPACT was started to improve the equity of healthcare services for patients with advanced colorectal cancer. 
• In the United Kingdom (UK), around 14,000 new cases of rectal cancer are diagnosed every year.
• It is estimated between 5% and 10% of rectal cancer will be locally advanced at presentation and may require surgical intervention.
• Furthermore, it is estimated approximately 10% of patients will develop a local recurrence following previous surgical intervention.
• The management of these patients is often complex and requires multidisciplinary surgical and oncological input. 

What is IMPACT I?

• IMPACT I is a research project SPonsored by Newcastle Upon Type Trust Hospitals and funded by ACPGBI and The Bowel Disease Research Foundation.
• The aim of IMPACT I is to provide patient-level data at an MDT level to identify decision-making and treatment strategies in patients with locally advanced rectal cancer and locally recurrent rectal cancer.
•